Table I.
miRNA | Up- or down-regulation | Target gene(s) | Target proteins | Cancer | References |
---|---|---|---|---|---|
miR-9 | Up | YC/MYCN | E-cadherin | Breast cancer cells | (35) |
miR-449a | Down | Rb | - | Prostate cancer cells | (36) |
miR-223 | Down | E2F1 | C/EBPα | Acute myeloid leukemia | (37) |
miR-34a and miR-34b/c | Down | P53 | CDK4/6, Cyclin E2, MET and Bcl-2 | Neuroblastoma, colorectal, lung, pancreatic, breast and ovarian cancer, bladder and renal cell carcinoma, liver carcinoma, oral squamous cell carcinoma, | (38,39) |
miR-21 | Up | Pdcd4 | u-PAR | Colon cancer | (40,41) |
miR-17–92 | Up | K-Ras and c-Myc | Tsp1 and CTGF | Colon cancer | (42) |
miR-145 | Down | TP53 | ER-α | Breast cancer cells | (43) |
miR- 483-3 and miR-421 | Up | DPC4/Smad4 | DPC4/Smad4 | Pancreatic cancer | (44,45) |
miR-224 | Up | CDC42, CDH1, PAK2, BCL-2 and MAPK1 | CDC42, CDH1, PAK2, BCL-2 and MAPK1 | Hepatocellular carcinoma | (46) |
miR-106b-25 | Up | Caspase-7 | Focal adhesion | Prostate cancer | (47) |
miR-34 | Down | Met and Bcl-2 | p53 | Lung adenocarcinoma | (48) |
miRNA, microRNA; Rb, retinoblastoma.